(Q47895423)

English

Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients

scientific article published on 11 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

10

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

Jose Castellote

object named as

José Castellote

5

0 references

Constantino Fondevila

object named as

Constantino Fondevila

3

0 references

author name string

Miguel Angel Gómez-Bravo

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

Magdalena Salcedo

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

Francisco Suarez

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

Sebastián Rufian

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

José Antonio Pons

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

José María Alamo

8

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

Olga Millán

9

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

publication date

11 September 2013

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

53

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

11

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

1146-1154

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Pharmacogenetics in immunosuppressants: impact on dose requirement of calcineurin inhibitors in renal and liver pediatric transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.154

21 January 2018

Identifiers

10.1002/JCPH.154

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/23900887

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47895423&oldid=2175006659"